Office reopening poses serious risks, with or without virus testing

CoronaWorries_Adobe_575x375
By Silas Brown
19 May 2020

Without a vaccine for the coronavirus, it is clear that reopening offices is a serious risk for capital markets businesses. What firms need are strict distancing measures, facial masks and hand sanitiser — but also, crucially, access to frequent testing for the virus and the antibody.But that is a path fraught with difficulty.

Without a vaccine, the world will not be rid of the coronavirus.

Many think a vaccine won’t be found till 2021. But before then, companies will be reopening offices as the daily death figures fall and lockdowns are eased.

Corporate management must therefore wrestle with matching up the ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.